Sucampo Pharmaceuticals Stock Probability Of Bankruptcy
Sucampo Pharmaceuticals fundamentals help investors to digest information that contributes to Sucampo Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Sucampo Stock. The fundamental analysis module provides a way to measure Sucampo Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sucampo Pharmaceuticals stock.
Sucampo |
Sucampo Pharmaceuticals Company probability of distress Analysis
Sucampo Pharmaceuticals' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability_Of_Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Sucampo Pharmaceuticals Probability Of Bankruptcy | Over 100% |
Most of Sucampo Pharmaceuticals' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sucampo Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Sucampo Pharmaceuticals probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Sucampo Pharmaceuticals odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Sucampo Pharmaceuticals financial health.
Please note, there is a significant difference between Sucampo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sucampo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sucampo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
CompetitionBased on the latest financial disclosure, Sucampo Pharmaceuticals has a Probability Of Bankruptcy of 100%. This is 131.0% higher than that of the sector and 39.22% higher than that of the Probability Of Bankruptcy industry. The probability of bankruptcy for all United States stocks is 151.07% lower than that of the firm.
Sucampo Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sucampo Pharmaceuticals' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sucampo Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Sucampo Pharmaceuticals by comparing valuation metrics of similar companies.Sucampo Pharmaceuticals is currently under evaluation in probability of bankruptcy category among related companies.
Sucampo Fundamentals
| Return On Equity | 14.16 | |||
| Return On Asset | 0.0296 | |||
| Profit Margin | 7.80 % | |||
| Operating Margin | 30.77 % | |||
| Current Valuation | 1.05 B | |||
| Shares Outstanding | 47.09 M | |||
| Shares Owned By Insiders | 35.13 % | |||
| Shares Owned By Institutions | 82.48 % | |||
| Number Of Shares Shorted | 4.59 M | |||
| Price To Earning | (2.77) X | |||
| Price To Book | 21.08 X | |||
| Price To Sales | 3.38 X | |||
| Revenue | 250.47 M | |||
| Gross Profit | 154.05 M | |||
| EBITDA | 107.24 M | |||
| Net Income | (150.89 M) | |||
| Cash And Equivalents | 75.04 M | |||
| Cash Per Share | 1.62 X | |||
| Total Debt | 293.54 M | |||
| Debt To Equity | 740.60 % | |||
| Current Ratio | 5.11 X | |||
| Book Value Per Share | 2.26 X | |||
| Cash Flow From Operations | 28.51 M | |||
| Short Ratio | 9.78 X | |||
| Earnings Per Share | (3.37) X | |||
| Price To Earnings To Growth | 5.30 X | |||
| Number Of Employees | 139 | |||
| Beta | 0.58 | |||
| Market Capitalization | 847.54 M | |||
| Total Asset | 457.18 M | |||
| Retained Earnings | 24.37 M | |||
| Working Capital | 163.23 M | |||
| Current Asset | 251.36 M | |||
| Current Liabilities | 88.13 M | |||
| Z Score | 1.2 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sucampo Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sucampo Pharmaceuticals' short interest history, or implied volatility extrapolated from Sucampo Pharmaceuticals options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Sucampo Stock
If you are still planning to invest in Sucampo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sucampo Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |